Chris Cleary insider trades
Open-market stock purchases and sales by Chris Cleary, Director at Orchestra BioMed Holdings, Inc, from SEC Form 4 filings since Feb 3, 2025.
Companies traded
- OBIO Orchestra BioMed Holdings, Inc: other filings, last Jun 24, 2026